Literature DB >> 19326073

Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin.

Francesc X Soriano1, Paul Baxter, Lyndsay M Murray, Michael B Sporn, Thomas H Gillingwater, Giles E Hardingham.   

Abstract

"Two-cysteine" peroxiredoxins are antioxidant enzymes that exert a cytoprotective effect in many models of oxidative stress. However, under highly oxidizing conditions they can be inactivated through hyperoxidation of their peroxidatic active site cysteine residue. Sulfiredoxin can reverse this hyperoxidation, thus reactivating peroxiredoxins. Here we review recent investigations that have shed further light on sulfiredoxin's role and regulation. Studies have revealed sulfiredoxin to be a dynamically regulated gene whose transcription is induced by a variety of signals and stimuli. Sulfiredoxin expression is regulated by the transcription factor AP-1, which mediates its up-regulation by synaptic activity in neurons, resulting in protection against oxidative stress. Furthermore, sulfiredoxin has been identified as a new member of the family of genes regulated by nuclear factor erythroid 2-related factor (Nrf2) via a conserved Aáë-acting antioxidant response element (ARE). As such, sulfiredoxin is likely to contribute to the net antioxidative effect of small molecule activators of Nrf2. As discussed here, the proximal AP-1 site of the sulfiredoxin promoter is embedded within the ARE, as is common with Nrf2 target genes. Other recent studies have shown that sulfiredoxin induction via Nrf2 may form an important part of the protective response to oxidative stress in the lung, preventing peroxiredoxin hyperoxidation and, in certain cases, subsequent degradation. We illustrate here that sulfiredoxin can be rapidly induced in vivo by administration of CDDO-TFEA, a synthetic triterpenoid inducer of endogenous Nrf2, which may offer a way of reversing peroxiredoxin hyperoxidation in vivo following chronic or acute oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326073      PMCID: PMC2837916          DOI: 10.1007/s10059-009-0050-y

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  36 in total

1.  Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.

Authors:  You Hyun Noh; Jin Young Baek; Woojin Jeong; Sue Goo Rhee; Tong-Shin Chang
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

2.  Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies.

Authors:  Qiou Wei; Hong Jiang; Connie P Matthews; Nancy H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-04       Impact factor: 11.205

3.  Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate.

Authors:  Thomas J Jönsson; Michael S Murray; Lynnette C Johnson; W Todd Lowther
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

4.  S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.

Authors:  Jianguo Fang; Tomohiro Nakamura; Dong-Hyung Cho; Zezong Gu; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

5.  Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace.

Authors:  Thomas J Jönsson; Lynnette C Johnson; W Todd Lowther
Journal:  Nature       Date:  2008-01-03       Impact factor: 49.962

Review 6.  Structure, mechanism and regulation of peroxiredoxins.

Authors:  Zachary A Wood; Ewald Schröder; J Robin Harris; Leslie B Poole
Journal:  Trends Biochem Sci       Date:  2003-01       Impact factor: 13.807

Review 7.  Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.

Authors:  S G Rhee; W Jeong; T-S Chang; H A Woo
Journal:  Kidney Int Suppl       Date:  2007-08       Impact factor: 10.545

8.  Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs.

Authors:  Anju Singh; Guoyu Ling; Avvaru N Suhasini; Ping Zhang; Masayuki Yamamoto; Ana Navas-Acien; Gregory Cosgrove; Rubin M Tuder; Thomas W Kensler; Walter H Watson; Shyam Biswal
Journal:  Free Radic Biol Med       Date:  2008-11-01       Impact factor: 7.376

9.  Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses.

Authors:  Sofia Papadia; Francesc X Soriano; Frédéric Léveillé; Marc-Andre Martel; Kelly A Dakin; Henrik H Hansen; Angela Kaindl; Marco Sifringer; Jill Fowler; Vanya Stefovska; Grahame McKenzie; Marie Craigon; Roderick Corriveau; Peter Ghazal; Karen Horsburgh; Bruce A Yankner; David J A Wyllie; Chrysanthy Ikonomidou; Giles E Hardingham
Journal:  Nat Neurosci       Date:  2008-03-23       Impact factor: 24.884

10.  Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione.

Authors:  Francesc X Soriano; Frédéric Léveillé; Sofia Papadia; Larry G Higgins; James Varley; Paul Baxter; John D Hayes; Giles E Hardingham
Journal:  J Neurochem       Date:  2008-09-16       Impact factor: 5.372

View more
  54 in total

1.  Gene Expression Profiling in Human Lung Cells Exposed to Isoprene-Derived Secondary Organic Aerosol.

Authors:  Ying-Hsuan Lin; Maiko Arashiro; Phillip W Clapp; Tianqu Cui; Kenneth G Sexton; William Vizuete; Avram Gold; Ilona Jaspers; Rebecca C Fry; Jason D Surratt
Journal:  Environ Sci Technol       Date:  2017-07-05       Impact factor: 9.028

2.  Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.

Authors:  Jason E Comer; Daniel E Sturdevant; Aaron B Carmody; Kimmo Virtaneva; Donald Gardner; Dan Long; Rebecca Rosenke; Stephen F Porcella; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

Review 3.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

4.  Reexamination of the electrophile response element sequences and context reveals a lack of consensus in gene function.

Authors:  Hongqiao Zhang; Henry Jay Forman
Journal:  Biochim Biophys Acta       Date:  2010-05-15

5.  The S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase 2 is reduced by interaction with glutathione peroxidase 3 in Saccharomyces cerevisiae.

Authors:  Phil Young Lee; Kwang-Hee Bae; Dae Gwin Jeong; Seung-Wook Chi; Jeong Hee Moon; Seongman Kang; Sayeon Cho; Sang Chul Lee; Byoung Chul Park; Sung Goo Park
Journal:  Mol Cells       Date:  2010-12-30       Impact factor: 5.034

Review 6.  The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.

Authors:  Murli Mishra; Hong Jiang; Lisha Wu; Hedy A Chawsheen; Qiou Wei
Journal:  Cancer Lett       Date:  2015-07-10       Impact factor: 8.679

7.  Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.

Authors:  Lisha Wu; Hong Jiang; Hedy A Chawsheen; Murli Mishra; Matthew R Young; Matthieu Gerard; Michel B Toledano; Nancy H Colburn; Qiou Wei
Journal:  Carcinogenesis       Date:  2014-02-06       Impact factor: 4.944

Review 8.  Mechanisms of Normal Tissue Injury From Irradiation.

Authors:  Deborah E Citrin; James B Mitchell
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

9.  Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.

Authors:  Murli Mishra; Hong Jiang; Hedy A Chawsheen; Matthieu Gerard; Michel B Toledano; Qiou Wei
Journal:  Cancer Lett       Date:  2018-06-15       Impact factor: 8.679

10.  Responses of cultured human keratocytes and myofibroblasts to ethyl pyruvate: a microarray analysis of gene expression.

Authors:  Stephen A K Harvey; Emily Guerriero; Nahthai Charukamnoetkanok; Jordan Piluek; Joel S Schuman; Nirmala Sundarraj
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.